Valeant increases its offer to acquire Obagi after Merz Pharma tops its previous offer last month. Cosmetics products maker Obagi Medical Products Inc.
Deals
IAG Closes Purchase Order of 787 Dreamliners from Boeing
International Airlines Group said it will be buying 18 787 Dreamliners from Boeing, which faced over lithium-ion battery overheating concerns.
Vodafone Considers Company Sale to Verizon
Vodafone shareholders are thinking about whether they should sell the entire company to Verizon or just sell its 45% stake.
Nationwide Financial Buys 17 Funds from Union Bank's HighMark
Nationwide Financial has announced that it is acquiring 17 equity and bond mutual funds with $3.6 billion in assets from Union Bank's HighMark Capital Management.
NFP Final Bidders Known
The finalists for the bids for NFP are TPG and Madison Dearborn. The two final bidders for wealth management company National Financial Partners are private equity firms TPG Capital and Madison Dearborn Partners.
Latest News
Obagi's enterprise value increased as Valeant offered a higher share value price of US$24 per share.
Dish Network would offer senior notes amounting to US$2.3 billion, double its previous announcement.
DAMAC Properties would be listing publicly in the Dubai bourse amidst high interest for IPOs in the region.
Midokura's network development software boosts its capital infusion with US$12M from INCJ and US$5.2M for other investors.
Telefonica Deutschland would be selling off Euro denominated bonds. The German subsidiary of Spain's largest phone company, Telefonica Deutschland Holding AG is now preparing to offer for sale of Euro denominated bonds as early as this month.
The German construction firm Hochtief is pushing to become leaner in its process to divest assets for the long term.
PT Saratoga Investama Sedaya and PT Mitra Pinasthika Mustika would be listed for their individual IPOs in Indonesia's bourse this year.
AstraZeneca purchases AlphaCore and its up and coming cholesterol drugs. AstraZeneca purchased through private placement US biotech company AlphaCore Pharma.
Astorg Partners leads the consortium that will purchase Canberra from Areva. Areva. the top nuclear reactor builder of France announced that it would be selling its nuclear radiation measurement subsidiary to a private equity group.
